Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Abcam	Sana Biotechnology	Cronos Group	Genus	Abcam
Symbol	NASDAQ:ABCM	NASDAQ:SANA	TSE:CRON	LON:GNS	LON:ABC
Price Information
Current Price	$20.11	$20.00	C$8.81	GBX 4,750	GBX 1,402
52 Week Range	Hold	Buy	Buy	Buy	Hold
MarketRank™
Overall Score	1.1	1.2	0.9	1.3	0.5
Analysis Score	1.2	3.3	2.3	1.3	1.1
Community Score	2.4	2.5	2.1	2.7	1.3
Dividend Score	0.0	0.0	0.0	0.8	0.0
Ownership Score	0.0	0.0	0.0	1.7	0.0
Earnings & Valuation Score	1.9	0.0	0.0	0.0	0.0
Analyst Ratings
Consensus Recommendation	Hold	Buy	Buy	Buy	Hold
Consensus Price Target	$22.00	$40.00	C$9.57	GBX 4,760	GBX 1,402
% Upside from Price Target	9.40% upside	100.00% upside	8.59% upside	0.21% upside	N/A
Trade Information
Market Cap	$4.56 billion	$3.75 billion	C$3.27 billion	£3.10 billion	£3.18 billion
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	171,297	587,628	877,988	105,596	443,731
Sales & Book Value
Annual Revenue	N/A	N/A	C$46.72 million	£566.40 million	£269.30 million
Price / Sales	N/A	N/A	70.08	5.48	11.80
Cashflow	N/A	N/A	C$3.37 per share	GBX 75.98 per share	GBX 91.97 per share
Price / Cash	N/A	N/A	2.61	62.51	15.24
Book Value	N/A	N/A	C$4.75 per share	GBX 769.20 per share	GBX 286.70 per share
Price / Book	N/A	N/A	1.85	0.06	0.05
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	N/A	N/A	C($0.26)	GBX 73.60	GBX (0.90)
Trailing P/E Ratio	0.00	0.00	N/A	64.54	N/A
Forward P/E Ratio	64.87	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	GBX 0.29	GBX 0.04
Dividend Yield	N/A	N/A	N/A	0.01%	0.00%
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	0.40%	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	0.58%	28.59%	18.58%
Current Ratio	N/A	N/A	6.63%	1.86%	5.58%
Quick Ratio	N/A	N/A	6.33%	1.26%	4.79%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	1,600	263	631	3,100	1,600
Shares Outstanding	226.72 million	187.68 million	371.66 million	65.31 million	226.73 million
Next Earnings Date	N/A	8/4/2021 (Estimated)	N/A	N/A	N/A
Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	Abcam plc (LON:ABC) Receives Consensus Rating of "Hold" from Analysts americanbankingnews.com - May 16 at 4:10 AM
	Epigenetic Market 2021 Size : Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2027 marketwatch.com - May 15 at 12:43 PM
	Abcam (LON:ABC) Share Price Crosses Below 200-Day Moving Average of $1,515.15 americanbankingnews.com - May 15 at 1:58 AM
	Kinetin Market Giants To Grow At Much Faster Pace \| Thermo Fisher Scientific, Cayman Chemical, Selleck Chemicals, Abcam, Gold Biotechnology, Merck industribune.net - May 14 at 4:39 PM
	An aged immune system drives senescence and ageing of solid organs nature.com - May 12 at 3:25 PM
	Human urine-derived stem cell-derived exosomal miR-21-5p promotes neurogenesis to attenuate Rett syndrome via the EPha4/TEK axis nature.com - May 11 at 7:46 AM
	Galactosyl Transferases market set to touch double digit cagr \| Abgent, R&D Systems, St John’s Laboratory, RayBiotech, Novus Biologicals, Covalab industribune.net - May 6 at 3:52 PM
	Abcam (LON:ABC) Share Price Passes Below Two Hundred Day Moving Average of $1,502.95 americanbankingnews.com - April 29 at 2:57 AM
	Ubiquitin Enzymes Market Analysis 2021 : Market Size, Growth, Trends, Opportunities Forecast To 2026 with Top Countries Data marketwatch.com - April 28 at 12:29 PM
	Trypsin Inhibitor Market Research Reports 2021- Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis 2027 marketwatch.com - April 27 at 11:24 AM
	MicroRNM Market 2021 Top Companies report covers are Abcam Plc,Illumina, Inc.,Agilent Technologies,Bio- and Market Share, Demand Forecast to 2025 marketwatch.com - April 21 at 7:00 AM
	Abcam plc (LON:ABC) Given Average Recommendation of "Hold" by Brokerages americanbankingnews.com - April 21 at 5:12 AM
	Antibody Services Market Next Big Thing : Major Giants- ThermoFisher, GenScript, Abcam sbwire.com - April 20 at 3:54 PM
	Immunoassay Kits Market Size 2021 Research Report by Direct Sales, Distributor, Trends, Product Type Detail and Forecast to 2025 marketwatch.com - April 19 at 12:42 PM
	In situ architecture of neuronal α-Synuclein inclusions nature.com - April 14 at 9:39 AM
	Trypsin Inhibitor Market to Deliver Prominent Growth & Striking Opportunities, Analysis, Demand, Growth by Top Key Players, Forecast 2026 marketwatch.com - April 12 at 12:45 PM
	Reovirus directly engages integrin to recruit clathrin for entry into host cells nature.com - April 12 at 12:45 PM
	Tangeretin Market Size 2021 by Market Estimates and Projections by Types, Applications, Trends and Forecast to 2027 marketwatch.com - April 9 at 8:50 AM
	Cambridge A-listers combine in SARS-CoV-2 move businessweekly.co.uk - April 7 at 9:27 AM
	Avacta Group signs deal to help scientists who are fighting the coronavirus pandemic yorkshirepost.co.uk - April 6 at 7:19 AM
	Avacta Group In Deal With ABCAM To Sell SARS-CoV-2 Spike Protein Affimer Reagents- Quick Facts markets.businessinsider.com - April 6 at 7:19 AM
	Avacta Announces Distribution Agreement With ABCAM plc finance.yahoo.com - April 6 at 7:19 AM
	SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance nature.com - April 1 at 2:24 PM
	Global Biomarkers Market (2021 to 2025) - Featuring 10X Genomics, Abbott Laboratories & Abcam Among Others - ResearchAndMarkets.com finance.yahoo.com - March 31 at 9:46 AM
	Abcam PLC Stock Shows Every Sign Of Being Fairly Valued gurufocus.com - March 30 at 5:39 AM

Date	Company	Brokerage	Action
3/15/2021	Abcam	SVB Leerink	Lower Price Target
3/12/2021	Abcam	Berenberg Bank	Reiterated Rating
3/9/2021	Abcam	JPMorgan Chase & Co.	Reiterated Rating
3/9/2021	Abcam	Royal Bank of Canada	Reiterated Rating
1/28/2021	Abcam	Morgan Stanley	Initiated Coverage
11/16/2020	Abcam	William Blair	Initiated Coverage
11/16/2020	Abcam	Bank of America	Initiated Coverage
3/8/2021	Sana Biotechnology	The Goldman Sachs Group	Initiated Coverage
5/11/2021	Cronos Group	Cowen	Lower Price Target
5/11/2021	Cronos Group	MKM Partners	Boost Price Target
5/10/2021	Cronos Group	Raymond James	Boost Price Target
5/10/2021	Cronos Group	Stifel Nicolaus	Lower Price Target
4/9/2021	Cronos Group	Jefferies Financial Group	Boost Price Target
3/2/2021	Cronos Group	Pi Financial	Boost Price Target
3/31/2020	Cronos Group	Canaccord Genuity	Downgrade
1/18/2021	Genus	Liberum Capital	Boost Price Target
6/30/2020	Genus	Peel Hunt	Reiterated Rating
4/1/2020	Genus	HSBC	Boost Price Target
11/14/2019	Genus	Peel Hunt	Reiterated Rating

(Data available from 5/16/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources